Certara, Inc. - CERT

SEC FilingsOur CERT Tweets

About Gravity Analytica

Recent News

  • 06.13.2025 - Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year
  • 06.13.2025 - A Quantitative Systems Pharmacology Model to Investigate the Crucial Role of Epithelial Damage in the Pathogenesis of Inflammatory Bowel Disease
  • 06.12.2025 - Faster Mapping from Source Data to Target SDTM
  • 06.11.2025 - Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance
  • 06.11.2025 - Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis
  • 06.10.2025 - EACPT 2025 CONGRESS
  • 06.09.2025 - What are the most common in vitro drug-drug interaction study gaps?
  • 06.05.2025 - On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana
  • 06.05.2025 - Transform Your PK/PD Workflow with AI and the Cloud
  • 06.05.2025 - Accelerate IVIVC Modeling: How Formulation Scientists Can Save Time and Reduce Clinical Study Burden

Recent Filings

  • 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.02.2025 - 4 Statement of changes in beneficial ownership of securities